Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Lexicon Pharmaceuticals (LXRX) Return on Equity (2024 - 2025)

Lexicon Pharmaceuticals (LXRX) has disclosed Return on Equity for 4 consecutive years, with 0.07% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Equity rose 32.0% to 0.07% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.07%, a 32.0% increase, with the full-year FY2011 number at 0.43%, down 106.0% from a year prior.
  • Return on Equity was 0.07% for Q4 2025 at Lexicon Pharmaceuticals, down from 0.07% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.07% in Q3 2025 to a low of 0.47% in Q2 2025.